Article
CD55 upregulation in T cells of COVID-19 patients suppresses type-I interferon responses
2 May 2025
Abstract excerpt
Complement overactivation, has been verified in COVID-19 patients. Complement regulatory proteins, including CD55, control complement overactivation thus eliminating complement deposition and cell lysis. We investigated complement regulatory protein expression in COVID-19 for potential deregulated expression patterns driving disease pathogenesis. Single-cell RNA-seq revealed increased PBMCs CD55 expression in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
